Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-02-22 @ 7:03 PM
Study NCT ID:
NCT03009058
Status:
TERMINATED
Last Update Posted:
2024-11-25
First Post:
2016-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer
Sponsor:
Immodulon Therapeutics Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-16
First Submit QC Date:
None
Study First Post Date:
2017-01-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-03-31
Results First Submit QC Date:
None
Results First Post Date:
2024-11-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-09
Last Update Post Date:
2024-11-25
Last Update Post Date Type:
ACTUAL